Safety, immunogenicity and antibody persistence of an inactivated hepatitis A vaccine in 4 to 15 year old children

By Castillo de Febres O.   Chacon de Petrola M.   Casanova de Escalona L.   Naveda O.   Naveda M.   Estopinan M.   Bordones G.   Zambrano B.   Garcia A.   Dumas R.  

Vaccine, Vol. 18, Iss. 7, 1999-11 ,pp. : 656-664

Elsevier

Access to resources Recommend Favorite

Long-term persistence of anti-HAV antibodies following active immunization with hepatitis A vaccine

By Maiwald H.   Jilg W.   Bock H.L.   Loscher T.   Sonnenburg F.v.  

Vaccine, Vol. 15, Iss. 4, 1997-03 ,pp. : 346-348

Elsevier

Access to resources Recommend Favorite

Long-term persistence of anti-HBs after vaccination with a recombinant DNA yeast-derived hepatitis B vaccine: 8-year results

By Van Herck K.   Van Damme P.   Thoelen S.   Meheus A.  

Vaccine, Vol. 16, Iss. 20, 1998-12 ,pp. : 1933-1935

Elsevier

Access to resources Recommend Favorite

Anamnestic response to administration of purified non-adsorbed hepatitis B surface antigen in healthy responders to hepatitis B vaccine with long-term non-protective antibody titres

By Dentico P.   Crovari P.   Lai P.L.   Ponzio F.   Safary A.   Pellegrino A.   Meurice F.   Di Pasquale A.   Tornieporth N.   Volpe A.   Icardi G.  

Vaccine, Vol. 20, Iss. 31, 2002-11 ,pp. : 3725-3730

Elsevier

Access to resources Recommend Favorite

Long-term duration of detectable neutralizing antibodies after administration of live-attenuated VEE vaccine and following booster vaccination with inactivated VEE vaccine

By Pittman P.R.   Makuch R.S.   Mangiafico J.A.   Cannon T.L.   Gibbs P.H.   Peters C.J.  

Vaccine, Vol. 14, Iss. 4, 1996-03 ,pp. : 337-343

Elsevier

Access to resources Recommend Favorite